Molecular and Cellular Therapeutics

submenu

From discovery to medicine

A unit of the Academic Health Center, Molecular and Cellular Therapeutics offers state-of-the-art GMP/GTP compliant, full-service development and manufacturing of cell- and tissue-based products, monoclonal antibodies and other therapeutic proteins, as well as active pharmaceutical ingredients, for use in Phase I, II or III clinical trials. 

Our fully-staffed technical and quality personnel with product development, medical, and regulatory expertise, work to compress development timelines and translate research into medicine.